2-HOBA: Multiple Dosing Study in Older Adults
Public ClinicalTrials.gov record NCT03556319. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
2-Hydroxybenzylamine: Multiple Dosing Study in Older Adults
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to test how well people tolerate a new dietary ingredient called 2-HOBA and how it is metabolized in the body. 2-HOBA is a compound that occurs naturally in buckwheat seeds. This dietary ingredient has been used in animal studies, and single doses have been tolerated well when given to a small group of healthy people. In this study we will test how well people tolerate taking 2-HOBA over 2 weeks and how it is metabolized by the body.
Study identification
- NCT ID
- NCT03556319
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 18 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 55 Years to 79 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 22, 2018
- Primary completion
- Jul 30, 2021
- Completion
- Jul 30, 2021
- Last update posted
- Dec 13, 2021
2018 – 2021
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Older Adults trials
Other public records listing Older Adults. Sorted by last update posted; newest first. Not a recommendation.
- NCT07780162: Wearable Sensor for Early Detection and Monitoring of Cognitive Decline Not yet recruiting
- NCT07760948: HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting Semaglutide Not yet recruiting
- NCT06588556: Improving Needs Among Older Adults Recruiting
- NCT06940843: A Pilot Randomized Controlled Trial of the Hopeful and Healthy Living Program Recruiting
- NCT06323954: tVNS During Motor Training in Older Adults Recruiting
- NCT07511621: A Multi-Level Strategy for De-implementing Mammography Overuse Among Older Women Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03556319, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 13, 2021 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03556319 live on ClinicalTrials.gov.